A comparative study on the effects of diet and exercise, metformin and metformin+pioglitazone treatment on NIDDM patients
- 1 September 2007
- journal article
- Published by Springer Science and Business Media LLC in Indian Journal of Clinical Biochemistry
- Vol. 22 (2), 65-69
- https://doi.org/10.1007/bf02913316
Abstract
A comparative study on two groups of newly diagnosed nonobese and obese NIDDM patients who were 15 in each group and treated by diet cum exercise and metfromin monotherapy respectively and a third group of 15 obese NIDDM patients whose hyperglycemia was not first controlled by a combination therapy of metformin and sulfonylurea and therefore changed over to a different combination therapy of metformin and ploglitazone, was carried out before and after a period of three months treatment. The mild hyperglycemia in the 1^st group and the moderate or severe hyperglycemia with accompanied disorders of serum enzymes such as AST, ALT, GGT and the level of HBA_10 observed with 2^nd and 3^rd groups of obese NIDDM patients were significantly ameliorated by the respective mode of treatments. Here the efficacies of the three types of treatment are substantiated and further it specifically depicts the success with the choice of combination therapy with metformin and pioglitazone in the third group of obese diabetics.Keywords
This publication has 18 references indexed in Scilit:
- Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group studyClinical Therapeutics, 2005
- Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.Diabetes Care, 2000
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Thiazolidinediones in the Treatment of Insulin Resistance and Type II DiabetesDiabetes, 1996
- Biguanides and NIDDMDiabetes Care, 1992
- Dietary Therapy in Diabetes Mellitus: Is There a Single Best Diet?Diabetes Care, 1991
- Exercise and Decreased Risk of NIDDMNew England Journal of Medicine, 1991
- Physical Activity and Reduced Occurrence of Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1991
- A new useful modification for the determination of γ-glutamyltranspeptidase activityClinica Chimica Acta; International Journal of Clinical Chemistry, 1966
- Standardization of hemoglobinometry II. The hemiglobincyanide methodClinica Chimica Acta; International Journal of Clinical Chemistry, 1961